Cryopreserved Platelets (CPP) for US FDA Licensure

Deadline:04 May 2026, 15:00 GMT-4

Tender information

SAM.gov

FORT DETRICK, United States

Type: Sources Sought
Procedure: Sources Sought
Ref. number: e2c26dc3937049faa715f6fa7fad2308
NAICS: 541715

Defense Health Agency seeks to develop and manage medical materiel to protect and sustain the Warfighter on point for the Nation. We develop, directly through collaboration with commercial partners, medical products that…

enhance readiness and improve the quality of life of active-duty personnel in the operational environment. OPMED�s WPAC PMO has been developing a biologic product: Dimethyl Sulfoxide (DMSO) Cryopreserved Platelets (CPP), a frozen, biologic-platelet product. DMSO CPP are formulated to provide a plat

elet-derived product with a longer shelf life (2 years and potentially longer) than liquid stored platelets (LSP), which are currently licensed for storage up to 5-7 days at room temperature (20�C to 24�C) under gentle agitation.

Show all tender information

Documents

Show all important dates